跳至主要内容
临床试验/NCT01731743
NCT01731743已完成不适用

Evaluation of Visual Acuity and Patient Satisfaction With AT LISA TRI 839MP Intraocular Lenses

Carl Zeiss Meditec AG2 个研究点 分布在 1 个国家目标入组 107 人开始时间: 2012年1月最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
入组人数
107
试验地点
2
主要终点
Intermediate visual acuity

研究概览

简要总结

The purpose of the study is to evaluate the far, intermediate and near visual acuities with a trifocal IOL.

详细描述

After bilateral cataract surgery, monocular and binocular uncorrected (UCVA) and best distance corrected visual acuity (BCVA) will be measured at far (4m), intermediate (80 cm) and near (40 cm) distance as well as the subjective refraction.

A patient questionnaire will be used to assess the patient satisfaction and spectacle independence.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Man or woman, over 50 years of age
  • Bilateral implantation of a trifocal intraocular lens
  • Capsular bag implantation

排除标准

  • Existing ocular pathology
  • Surgical complications
  • Corneal astigmatism ≥ 1.0D

研究组 & 干预措施

implantation of a trifocal IOL (AT LISA tri 839MP)

Other

干预措施: AT LISA tri 839MP (Device)

结局指标

主要结局

Intermediate visual acuity

时间窗: up to 3 months postoperatively

Monocular and binocular uncorrected and best distance corrected

次要结局

  • near and far visual acuity(1 and 3 month postoperatively)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验